Continuous Venovenous Hemofiltration: An Alternative to Continuous Arteriovenous Hemofiltration and Hemodiafiltration in Acute Renal Failure

Macias, William L.; Mueller, Bruce A.; Scarim, Sheila Kelly; Robinson, Merryn A.; Rudy, David W.

doi:10.1016/s0272-6386(12)80113-2

Cited by 83 publications

(40 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Therefore, continuous HF was used initially as a slow, continuous renal replacement therapy. 13) Continuous HF was performed with a specific hemofilter (Hemofeel  ; Toray, Tokyo) using nafamostat mesilate (20-30 mg/hr) as anticoagulant. Replacement solution (Sublood  -B; Fuso, Tokyo) was delivered at 15-20 l/20-24 hrs.…”

Section: Blood Purification After Admissionmentioning

confidence: 99%

Clinical Features and Management of Intracranial Hemorrhage in Patients Undergoing Maintenance Dialysis Therapy

Murakami

Hamasaki

Kimura

et al. 2004

Neurol. Med. Chir.(Tokyo)

View full text Add to dashboard Cite

The management and outcome were retrospectively investigated in patients with chronic renal failure receiving maintenance blood purification who suffered intracranial hemorrhage. Patients with intracerebral hemorrhage (ICH, n ＝ 36) or subarachnoid hemorrhage (SAH, n ＝ 5) were evaluated. Both groups were initially managed using continuous hemofiltration (HF) after admission, except for two patients with SAH receiving maintenance peritoneal dialysis. Patients with ICH were managed with HF three times a week after computed tomography showed decreased peripheral edema. Nafamostat mesilate was used as the anticoagulant for both continuous HF and HF. Hemodialysis (HD) three times a week was initiated after confirming the absence of neurological deterioration using HF. Craniotomy was not performed in any patient with ICH, but if necessary, the hematoma was aspirated using burr-hole surgery. Angiography was performed on the day of admission in patients with SAH. Delayed neck-clipping surgery was performed after continuous HF for 2 weeks with lumbar cerebrospinal fluid drainage. In patients with ICH, continuous HF was continued for 2-9 days after admission (mean 5.2 ± 2.2 days), followed by 2-9 courses of HF (mean 4.7 ± 2.1 courses). HD was initiated 9-26 days after admission (mean 15.5 ± 4.6 days). Favorable outcomes were achieved by 13 of the 36 patients with ICH and two of the five patients with SAH, whereas 22 patients with ICH and three patients with SAH died. Death occurred in 12 of 16 patients with ICH and diabetic nephropathy. In contrast, 10 of 20 non-diabetic patients with ICH had favorable outcomes. Ten of the 16 patients with initial GCS Ã8 and six of the 20 with GCS AE9 were diabetic. Therefore, there were significant differences between diabetic and non-diabetic patients (p ＝ 0.05). Poor outcomes in diabetic patients with ICH are caused by primary brain damage, reflected in the initial disturbance of consciousness.

show abstract

Section: Blood Purification After Admissionmentioning

confidence: 99%

Clinical Features and Management of Intracranial Hemorrhage in Patients Undergoing Maintenance Dialysis Therapy

Murakami

Hamasaki

Kimura

et al. 2004

Neurol. Med. Chir.(Tokyo)

View full text Add to dashboard Cite

show abstract

“…18 At the same time, relevant advances have occurred in related fields, including critical care medicine, nephrology, and transfusion medicine. [19][20][21] The collective impact of these advances on patient outcome is unknown. To address this matter, we assessed the change in TRM after transplantations for acute myeloid leukemia (AML), the most common indication for allogeneic HCT, 22 from 1985 to 2004.…”

Section: Introductionmentioning

confidence: 99%

Reducing the Risk for Transplantation-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made?

Horan

Logan

Agovi

et al. 2011

JCO

174

129

View full text Add to dashboard Cite

A B S T R A C T PurposeTransplantation-related mortality (TRM) is a major barrier to the success of allogeneic hematopoietic cell transplantation (HCT). Patients and MethodsWe assessed changes in the incidence of TRM and overall survival from 1985 through 2004 in 5,972 patients younger than age 50 years who received myeloablative conditioning and HCT for acute myeloid leukemia (AML) in first complete remission (CR1) or second complete remission (CR2). ResultsAmong HLA-matched sibling donor transplantation recipients, the relative risks (RRs) for TRM were 0.5 and 0.3 for 2000 to 2004 compared with those for 1985 to 1989 in patients in CR1 and CR2, respectively (P Ͻ .001). The RRs for all causes of mortality in the latter period were 0.73 (P ϭ .001) and 0.60 (P ϭ .005) for the CR1 and CR2 groups, respectively. Among unrelated donor transplantation recipients, the RRs for TRM were 0.73 (P ϭ .095) and 0.58 (P Ͻ .001) for 2000 to 2004 compared with those in 1990 to 1994 in the CR1 and CR2 groups, respectively. Reductions in mortality were observed in the CR2 group (RR, 0.74; P ϭ .03) but not in the CR1 group. ConclusionOur results suggest that innovations in transplantation care since the 1980s and 1990s have reduced the risk of TRM in patients undergoing allogeneic HCT for AML and that this reduction has been accompanied by improvements in overall survival. J Clin

show abstract

“…En esta última situación se ha aplicado con éxito técnicas derivadas como hemofiltración contínua arteriovenosa, hemofiltración contínua veno-venosa o hemodiafiltración contínua arteriovenosa (14,15,16,17,18).…”

Section: Discussionunclassified

Hemofiltración veno-venosa en el tratamiento de la insuficiencia renal aguda.

Estremadoyro¹,

Loza²,

Zevallos³

2013

Rev Med Hered

View full text Add to dashboard Cite

SUMMARYWe describe and analyze 30 veno-venous hemofiltration procedures in 22 adult patients with diagnosis of acute renal failure, between September 1991 and July 1992. We used Hospal Polycrylonitrile AN-69 filters (1.0, 1.2 and 1.7m2 ) and Duodial machines, designed and made in Peru. The procedure efficiency was evaluated through low weight solute (urea, creatinine, uric acid) clearances and the correlation between the basal concentration of seric electrolytes (sodium, calcium and phosphorus) and the deltas obtained at the end of the sessions. The clearances were: urea 62.6 ±17.5, creatinine 56.7±23.4 and uric acid 47.5±15.6 ml/min. The solutes clearances improved by increasing the venous resistence in the extracorporal circuit (r=0.63, p<0.005). the electrolyte imbalances were adecuately corrected: natremia r=0.54, p<0.05, kalemia r=0.65, p<0.05, calcemia r=0.76, p<0.05, phosphatemia r=0.27, p ns. The hemodynamic evolution was studied through the correlation between the sistolic and diastolic basal pressures and the deltas at the end of the session. Our dates confirm the low risk of hemodynamic disequilibrium in hemofiltration. The sistolic blood pressure correlation was -0.62 (p<0.05) and -0.54 (p<0.05) for the diastolic pressure. Low costs and efficiency make possible to set up descentralized renal units where hemofiltration could be used as substitution therapy for patients with renal failure. (Rev Med Hered 1994; 5:75-79).KEY WORDS: Hemofiltration, acute renal failure, cholera. RESUMENDescribimos y analizamos la experiencia obtenida en treinta procedimientos de Hemofiltración veno-venosa (HFVV) realizados en veintidós pacientes adultos con insuficiencia renal aguda, entre setiembre de 1991 y Julio de 1992. Utilizamos filtros Hospal-poliacrilonitrilo AN-69 (1.0, 1.2 Y 1.7m2 ) y máquinas Duodial de diseño y fabricación nacional. Evaluamos la eficiencia del procedimiento a través de los aclaramientos de solutos de pequeño peso molecular (úrea, creatinina y ácido úrico) y de la comparación entre las concentraciones basales de electrolitos (sodio, potasio,

show abstract

Continuous Venovenous Hemofiltration: An Alternative to Continuous Arteriovenous Hemofiltration and Hemodiafiltration in Acute Renal Failure

Cited by 83 publications

References 22 publications

Clinical Features and Management of Intracranial Hemorrhage in Patients Undergoing Maintenance Dialysis Therapy

Clinical Features and Management of Intracranial Hemorrhage in Patients Undergoing Maintenance Dialysis Therapy

Reducing the Risk for Transplantation-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made?

Hemofiltración veno-venosa en el tratamiento de la insuficiencia renal aguda.

Contact Info

Product

Resources

About